Clovis Oncology to Present at the Credit Suisse Annual Healthcare Conference
BOULDER, Colo. -- November 08, 2012
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J. Mahaffy,
the Company’s president and CEO, will present at the Credit Suisse Annual
Healthcare Conference on Thursday, November 15, at 11:30am MST. The conference
is being held at the Arizona Biltmore Hotel in Phoenix, Arizona.
A live webcast of the corporate presentation at the conference will be
accessible through the investor relations section of the Company’s website at
www.clovisoncology.com. Following the live presentation, a replay of the
webcast will be available on the Company’s website for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring,
developing and commercializing innovative anti-cancer agents in the U.S.,
Europe and additional international markets. Clovis Oncology targets
development programs at specific subsets of cancer populations, and
simultaneously develops diagnostic tools that direct a compound in development
to the population that is most likely to benefit from its use. Clovis Oncology
is headquartered in Boulder, Colorado, and has additional offices in San
Francisco, California and Cambridge, UK.
Clovis Oncology, Inc.
Anna Sussman, 303-625-5022
Breanna Burkart, 303-625-5023
Press spacebar to pause and continue. Press esc to stop.